New national ‘holistic’ diabetes scheme unveiled
The changes, contained in a briefing document from the company running the diabetes pilot, McKinsey & Co, are the first indication that the federal government plans to redesign the bulk of its $436 million diabetes scheme following intense criticism from doctors last year.
According to the document, the two-year trial involving 150 practices across three states will still feature an unspecified lump-sum payment for GPs treating diabetics – but that payment will now replace only MBS rebates for GP management plans, team care arrangements and reviews.
“It is important to note that this system will not replace MBS items for regular GP visits [by patients with diabetes] which will continue to be claimed on a fee-for-service basis,” the document says.
Practices would also receive funding to employ a “care facilitator”, a new role suggested by AMA Victoria.
The McKinsey paper said the role would &ldquo